These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 8203951

  • 21. Modifications of general parameters of immune activation in the sera of Sicilian patients with Boutonneuse fever.
    Mansueto S, Vitale G, Mocciaro C, Gambino G, Colletti P, Mansueto P, Spinelli A, Affronti M, Chifari N, Arcoleo F, Milano S, Cillari E.
    Clin Exp Immunol; 1998 Mar; 111(3):555-8. PubMed ID: 9528898
    [Abstract] [Full Text] [Related]

  • 22. Soluble interleukin-2 receptor and soluble CD8 antigen levels in serum from patients with solid tumors.
    Orditura M, De Vita F, Roscigno A, Auriemma A, Infusino S, Catalano G.
    Int J Mol Med; 1998 Jul; 2(1):75-9. PubMed ID: 9854147
    [Abstract] [Full Text] [Related]

  • 23. Rises in anti-double stranded DNA antibody levels prior to exacerbations of systemic lupus erythematosus are not merely due to polyclonal B cell activation.
    ter Borg EJ, Horst G, Hummel E, Limburg PC, Kallenberg CG.
    Clin Immunol Immunopathol; 1991 Apr; 59(1):117-28. PubMed ID: 2019007
    [Abstract] [Full Text] [Related]

  • 24. Increased soluble IL-2 receptor in serum of patients with systemic lupus erythematosus.
    Sawada S, Hashimoto H, Iijma S, Tokano Y, Matsukawa Y, Takei M, Ishikawa H, Kang H, Tomura K, Mitamura K.
    Clin Rheumatol; 1993 Jun; 12(2):204-9. PubMed ID: 8358979
    [Abstract] [Full Text] [Related]

  • 25. Lack of association between hyperprolactinemia and soluble IL-2 receptor levels in systemic lupus erythematosus.
    Daza L, Lavalle C, Duarte C, Huerta R, Moreno J.
    Lupus; 2003 Jun; 12(2):107-11. PubMed ID: 12630754
    [Abstract] [Full Text] [Related]

  • 26. B cell activation in clinically quiescent systemic lupus erythematosus (SLE) is related to immunoglobulin levels, but not to levels of anti-dsDNA, nor to concurrent T cell activation.
    Spronk PE, vd Gun BT, Limburg PC, Kallenberg CG.
    Clin Exp Immunol; 1993 Jul; 93(1):39-44. PubMed ID: 8100746
    [Abstract] [Full Text] [Related]

  • 27. Soluble interleukin-2 receptor, soluble CD8 and soluble intercellular adhesion molecule-1 levels in hematologic malignancies.
    Srivastava MD, Srivastava A, Srivastava BI.
    Leuk Lymphoma; 1994 Jan; 12(3-4):241-51. PubMed ID: 7909467
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Patterns of cytokines and soluble cellular receptors in the sera of children with acute chagas' disease.
    Moretti E, Basso B, Cervetta L, Brigada A, Barbieri G.
    Clin Diagn Lab Immunol; 2002 Nov; 9(6):1324-7. PubMed ID: 12414768
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Soluble interleukin 2 receptor levels in serum and its relationship to T cell abnormality and clinical manifestations of the disease in patients with systemic lupus erythematosus.
    Raziuddin S, al-Janadi MA, al-Wabel AA.
    J Rheumatol; 1991 Jun; 18(6):831-6. PubMed ID: 1680190
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.